[go: up one dir, main page]

BRPI0418963A - localized fat reduction composition, use of pharmaceutically acceptable surfactant compounds and methods for localized fat reduction - Google Patents

localized fat reduction composition, use of pharmaceutically acceptable surfactant compounds and methods for localized fat reduction

Info

Publication number
BRPI0418963A
BRPI0418963A BRPI0418963-9A BRPI0418963A BRPI0418963A BR PI0418963 A BRPI0418963 A BR PI0418963A BR PI0418963 A BRPI0418963 A BR PI0418963A BR PI0418963 A BRPI0418963 A BR PI0418963A
Authority
BR
Brazil
Prior art keywords
fat reduction
localized fat
methods
pharmaceutically acceptable
acceptable surfactant
Prior art date
Application number
BRPI0418963-9A
Other languages
Portuguese (pt)
Inventor
Marina Emiko Yagima Odo
Luiz Carlos Cuce
Original Assignee
Libbs Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libbs Farmaceutica Ltda filed Critical Libbs Farmaceutica Ltda
Publication of BRPI0418963A publication Critical patent/BRPI0418963A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPOSIçãO PARA REDUçãO DE GORDURA LOCALIZADA, USO DE COMPOSTOS TENSOATIVOS FARMACEUTICAMENTE ACEITáVEIS E MéTODOS PARA REDUçãO DE GORDURA LOCALIZADA A presente invenção refere-se ao uso do ácido cólico e/ou seus derivados na redução de gordura localizada no corpo humano, em que o agente ativo é preferencialmente usado subcutaneamente.LOCALIZED FAT REDUCTION COMPOSITION, USE OF PHARMACEUTICALLY ACCEPTABLE TENSOUS COMPOUNDS AND METHODS FOR LOCALIZED FAT Reduction The present invention relates to the use of colic acid and / or derivatives thereof in the localized fat reduction in the human body, wherein the active agent It is preferably used subcutaneously.

BRPI0418963-9A 2004-07-20 2004-07-20 localized fat reduction composition, use of pharmaceutically acceptable surfactant compounds and methods for localized fat reduction BRPI0418963A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2004/000123 WO2006007675A1 (en) 2004-07-20 2004-07-20 Cholic acid and/or its derivatives for the reduction of localized fat in the human body

Publications (1)

Publication Number Publication Date
BRPI0418963A true BRPI0418963A (en) 2007-12-04

Family

ID=35784823

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418963-9A BRPI0418963A (en) 2004-07-20 2004-07-20 localized fat reduction composition, use of pharmaceutically acceptable surfactant compounds and methods for localized fat reduction

Country Status (3)

Country Link
AR (1) AR049210A1 (en)
BR (1) BRPI0418963A (en)
WO (1) WO2006007675A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2422789T1 (en) * 2004-05-19 2018-07-31 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center An injectable composition comprising sodium deoxycholate
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX363465B (en) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Treatment of submental fat.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9426242B2 (en) * 2013-01-29 2016-08-23 Apple Inc. Determining an invitational content item type based on predicted user attention
KR102230271B1 (en) * 2019-11-13 2021-03-19 이환석 Injectable formulation and composition for reducing of fat comprising Glycodeoxycholic acid
JP2024535386A (en) * 2022-07-05 2024-09-30 グロノバ ファーマ シーオー．，エルティディー． Injectable compositions comprising a cytolytic compound in a gel, gel-forming solution, or gel-forming suspension for fat reduction - Patents.com

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591687A (en) * 1968-03-13 1971-07-06 George A Bray Bile acids and derivatives thereof as anorectic agents
IT1137459B (en) * 1981-04-14 1986-09-10 Erregierre Spa PRODUCTION FOR THE PREPARATION OF HIGH PURITY URSODEOXICOLIC ACID
JPS60130522A (en) * 1983-12-19 1985-07-12 Masatoshi Nakano Lipid metabolic promoter for fish
LU88373A1 (en) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Weight loss product
US20040019027A1 (en) * 2002-04-12 2004-01-29 Barry Forman Method of treating cerebrotendinous xanthomatosis

Also Published As

Publication number Publication date
WO2006007675A1 (en) 2006-01-26
AR049210A1 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
CU20090103A7 (en) DERIVATIVES OF 2,3-DIHYDROIMIDAZOL [1,2-C] QUINAZOLINE SUBSTITUTED FOR USEFULNESS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
EA200900638A1 (en) SALTS AND CRYSTAL FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDROIMIDAZO [4,5-c] CHINOLIN-1-IL) PHENYL] Propionitrile
AR034900A1 (en) USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
BRPI0810118A8 (en) METHOD TO TREAT DISEASE, METHOD TO EFFECT CAA PROPHYLAXIS, USE OF AN AGENT, METHOD TO REDUCE VASCULAR AMYLOID IN A PATIENT, AND, KIT FOR TREATMENT
BR0205722A (en) Prolonged release formulation and method for treating a patient suffering from pain
CU23367A3 (en) FORMULATION OF MOXIFLOXACINO WITH COMMON SALT
BR0109729A (en) Use of a combination of an anti-angiogenic agent and an antihypertensive agent, kit for use in producing an anti-angiogenic effect and / or vascular permeability reducing effect in a warm-blooded animal, and method of treating a unhealthy state associated with angiogenesis
BR0111358A (en) Thioacetamide compounds and their use
ITRE20110043A1 (en) SANITARY AGENT COVERED WITH FILM
BRPI0509086A (en) use of pde iii inhibitors to reduce heart size in mammals suffering from cardiac arrest
BR0306501A (en) Method for use and production of a medicated buffer
BRPI0308663B8 (en) use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
IL192100A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
AR049829A1 (en) PROCEDURE AND USEFUL COMPOSITIONS TO PREVENT AND / OR TREAT SENSITIVE AND / OR DRY SKIN
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR0104282A (en) Barrier agent for an absorbent article and an absorbent article
BRPI0912112B8 (en) pharmaceutical composition comprising compound having a2a adenosine receptor antagonistic activity useful in suppressing analgesic tolerance
EA200700214A1 (en) MEMANTINE AS AN ADDITIONAL THERAPY FOR ATYPICAL ANTIPSYCHOTIC REMEDIES IN PATIENTS WITH SCHIZOPHRENIA
BR0307041A (en) Phospholipid bodies and their use in the treatment of inflammatory and autoimmune diseases
BRPI0418963A (en) localized fat reduction composition, use of pharmaceutically acceptable surfactant compounds and methods for localized fat reduction
BRPI0712561B8 (en) Use of 3-oxo-3,4-dihydro-2-pyrazinecarboxamide
PT2465493E (en) Topical compositions for the prevention and treatment of irritation of mucous cells
BRPI0413474A (en) interferon and ribavirin use and kit for use in the treatment of viral infections
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2008145943A3 (en) Vehicle in the form of a water-in-oil emulsion in particular for ophthalmic or dermocosmetic use

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B25G Requested change of headquarter approved

Owner name: LIBBS FARMACEUTICA LTDA (BR/SP)

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B09B Decision: refusal